892 related articles for article (PubMed ID: 23688540)
21. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
[TBL] [Abstract][Full Text] [Related]
22. Pharmaceutical care research and education project: pharmacists' interventions.
Kassam R; Farris KB; Burback L; Volume CI; Cox CE; Cave A
J Am Pharm Assoc (Wash); 2001; 41(3):401-10. PubMed ID: 11372905
[TBL] [Abstract][Full Text] [Related]
23. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables.
Wuyts J; Maesschalck J; De Wulf I; Lelubre M; Foubert K; De Vriese C; Boussery K; Goderis G; De Lepeleire J; Foulon V
Res Social Adm Pharm; 2020 Aug; 16(8):1100-1110. PubMed ID: 31759887
[TBL] [Abstract][Full Text] [Related]
24. The status of the performance of medication reviews in German community pharmacies and assessment of the practical performance.
Greißing C; Kössler K; Freyer J; Hüter L; Buchal P; Schiek S; Bertsche T
Int J Clin Pharm; 2016 Dec; 38(6):1425-1435. PubMed ID: 27783313
[TBL] [Abstract][Full Text] [Related]
25. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
[TBL] [Abstract][Full Text] [Related]
26. Using the costs of drug therapy to screen patients for a community pharmacy-based medication review program.
Krähenbühl JM; Decollogny A; Bugnon O
Pharm World Sci; 2008 Dec; 30(6):816-22. PubMed ID: 18551382
[TBL] [Abstract][Full Text] [Related]
27. Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial.
Williams M; Peterson GM; Tenni PC; Bindoff IK; Curtain C; Hughes J; Bereznicki LR; Jackson SL; Kong DC; Hughes JD
Ann Pharmacother; 2011 Sep; 45(9):1067-76. PubMed ID: 21878658
[TBL] [Abstract][Full Text] [Related]
28. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
Blake KB; Madhavan SS
Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
[TBL] [Abstract][Full Text] [Related]
29. Implementing a pharmacist-led in-home medication coaching service via community-based partnerships.
Akers JL; Meer G; Kintner J; Shields A; Dillon-Sumner L; Bacci JL
J Am Pharm Assoc (2003); 2019; 59(2):243-251. PubMed ID: 30638730
[TBL] [Abstract][Full Text] [Related]
30. Individual medication management system (IMMS) implementation in pharmacists' opinion.
Waszyk-Nowaczyk M; Lawicki S; Michalak M; Simon M
Acta Pol Pharm; 2014; 71(3):509-14. PubMed ID: 25265831
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the economic impact of a targeted medication intervention program.
Rhodes SA; Reynolds AE; Marciniak MW; Ferreri SP
J Pharm Pract; 2013 Dec; 26(6):562-73. PubMed ID: 23804242
[TBL] [Abstract][Full Text] [Related]
32. Children/young people taking long-term medication: a survey of community pharmacists' experiences in England.
Aston J; Wilson KA; Terry DRP
Int J Pharm Pract; 2018 Apr; 26(2):104-110. PubMed ID: 28370586
[TBL] [Abstract][Full Text] [Related]
33. Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study.
Szilvay A; Somogyi O; Meskó A; Zelkó R; Hankó B
BMC Health Serv Res; 2019 May; 19(1):282. PubMed ID: 31053135
[TBL] [Abstract][Full Text] [Related]
34. Exploring opportunities for providing pharmacists with feedback on their practice and performance around the electronic Minor Ailments Service in Scotland.
Paudyal V; Hansford D; Cunningham S; Stewart D
Int J Pharm Pract; 2014 Oct; 22(5):319-26. PubMed ID: 24423237
[TBL] [Abstract][Full Text] [Related]
35. Community pharmacists' perspectives on implementation of Medicines Use Review in Slovenia.
Nabergoj Makovec U; Kos M; Pisk N
Int J Clin Pharm; 2018 Oct; 40(5):1180-1188. PubMed ID: 29909563
[TBL] [Abstract][Full Text] [Related]
36. Medication use review in Qatar: are community pharmacists prepared for the extended professional role?
Babiker AH; Carson L; Awaisu A
Int J Clin Pharm; 2014 Dec; 36(6):1241-50. PubMed ID: 25293711
[TBL] [Abstract][Full Text] [Related]
37. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
38. Community pharmacists' perceptions of services that benefit older people in New Zealand.
Tordoff J; Chang SY; Norris PT
Int J Clin Pharm; 2012 Apr; 34(2):342-50. PubMed ID: 22328011
[TBL] [Abstract][Full Text] [Related]
39. Medication reviews in primary care in Sweden: importance of clinical pharmacists' recommendations on drug-related problems.
Modig S; Holmdahl L; Bondesson Å
Int J Clin Pharm; 2016 Feb; 38(1):41-5. PubMed ID: 26582483
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive medication reviews for elderly patients: findings and recommendations to physicians.
Leikola SN; Virolainen J; Tuomainen L; Tuominen RK; Airaksinen MS
J Am Pharm Assoc (2003); 2012; 52(5):630-3. PubMed ID: 23023843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
